Oryzon Genomics S.A. (ORY.MC)

EUR 1.59

(-3.98%)

Annual Cash Flows

(In EUR)
Breakdown 2023 2022 2021 2020 2019
Operating Cash Flow -574.96 Thousand -1.84 Million -3.62 Million -4.81 Million -
Net Income -6.1 Million -6.55 Million -7.17 Million -4.77 Million -
Depreciation & Amortization 152.88 Thousand 166.66 Thousand 144.33 Thousand 145.05 Thousand -
Deferred income taxes - - - - -
Stock-based compensation - - - - -
Change in working capital -761.79 Thousand 1.25 Million 2.13 Million -1.22 Million -
Other non-cash items 1.93 Million 1.04 Million 572.53 Thousand 436.81 Thousand -
Investing Cash Flow -14.5 Million -14.27 Million -11.72 Million -9.08 Million -
Investments in PPE -14.5 Million -14.27 Million -11.76 Million -9.22 Million -
Acquisitions - - - - -
Investment purchases -1225.00 -799.00 -6189.00 - -
Sales/Maturities of investments 272.00 147.00 43.2 Thousand 141.55 Thousand -
Other Investing Activities -14.5 Million - - 141.55 Thousand -
Financing Cash Flow 6.02 Million 8.7 Million 4.12 Million 18.38 Million -
Debt repayment -7.9 Million -9.64 Million -4.12 Million -200.49 Thousand -
Dividends payments - - - - -
Common Stock Repurchased -1.8 Million - - - -
Common Stock Issuance - - - 22.08 Million 20.49 Million
Other Financing Activities -1.87 Million -932.26 Thousand - 18.18 Million 18.37 Million
Accounts receivables 336.35 Thousand - - - -
Accounts payables - - - - -
Inventory 3769.00 93.99 Thousand 213.03 Thousand -28.02 Thousand -
Other working capital -1.1 Million - - - -
Cash at beginning of period 21.31 Million 28.72 Million 39.6 Million 35.11 Million -
Cash at end of period 12.25 Million 21.31 Million 28.72 Million 39.6 Million -
Capital Expenditure -14.5 Million -14.27 Million -11.76 Million -9.22 Million -
Effect of forex changes on cash -2625.00 1086.00 347.65 Thousand 11.2 Thousand -
Net cash flow / Change in cash -9.05 Million -7.4 Million -10.88 Million 4.49 Million -
Free Cash Flow -15.07 Million -16.11 Million -15.38 Million -14.04 Million -

Cash Flow Charts